PMID- 22457418 OWN - NLM STAT- MEDLINE DCOM- 20130621 LR - 20130117 IS - 1941-2444 (Electronic) IS - 0148-6071 (Linking) VI - 37 IP - 1 DP - 2013 Jan TI - Influence of the slow infusion of a soybean oil emulsion on plasma cytokines and ex vivo T cell proliferation after an esophagectomy. PG - 123-8 LID - 10.1177/0148607112442216 [doi] AB - BACKGROUND: Lipid emulsions have been suggested to reduce immune responses, particularly in severely stressed patients. The authors investigated the influence of the slow intravenous infusion of a soybean oil-based lipid emulsion on some immune parameters in patients who had undergone an esophagectomy for esophageal cancer. METHODS: Thirty-two patients who had undergone an esophagectomy were randomly divided into a lipid emulsion (LPD)-treated group and a control group. All patients received parenteral feeding with a glucose-based solution. Patients in the LPD group received 100 mL of a 20% soybean oil emulsion for 7 days after the esophagectomy in addition to the glucose-based feeding. A slow infusion rate (0.09-0.12 g/kg/h) was adopted to take account of the intrinsic degradation of infused lipids. Immune responses were measured based on lymphocyte proliferation and serum concentrations of monocyte chemoattractant protein-1 (MCP-1), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-alpha). The authors also measured levels of rapid turnover proteins (ie, transferrin, prealbumin, and retinol-binding protein). RESULTS: Phytohemagglutinin- and concanavalin A-stimulated lymphocyte proliferation significantly decreased after the esophagectomy, but no significant difference was seen between the LPD and control groups. No significant difference in changes in plasma concentrations of MCP-1, IL-6 and TNF-alpha occurred between the 2 groups either. Plasma concentrations of rapid turnover proteins did not differ between the groups. CONCLUSIONS: These results indicate that the lipid emulsion did not affect the immune parameters measured in patients who had undergone an esophagectomy when administered at a slow rate. FAU - Kagawa, Yoshiyuki AU - Kagawa Y AD - Department of Clinical Pharmaceutics, University of Shizuoka, Shizuoka, Japan. kagaway@u-shizuoka-ken.ac.jp FAU - Maeda, Toshio AU - Maeda T FAU - Kato, Yasuhiro AU - Kato Y FAU - Ueda, Iori AU - Ueda I FAU - Kudo, Tomoko AU - Kudo T FAU - Watanabe, Naoe AU - Watanabe N FAU - Kimura, Midori AU - Kimura M FAU - Minami, Sato AU - Minami S FAU - Sakamoto, Tatsuichiro AU - Sakamoto T FAU - Yamada, Hiroshi AU - Yamada H FAU - Takagi, Masakazu AU - Takagi M LA - eng PT - Journal Article PT - Randomized Controlled Trial DEP - 20120328 PL - United States TA - JPEN J Parenter Enteral Nutr JT - JPEN. Journal of parenteral and enteral nutrition JID - 7804134 RN - 0 (Chemokine CCL2) RN - 0 (Cytokines) RN - 0 (Fat Emulsions, Intravenous) RN - 0 (Interleukin-6) RN - 0 (Phytohemagglutinins) RN - 0 (Tumor Necrosis Factor-alpha) RN - 11028-71-0 (Concanavalin A) RN - 8001-22-7 (Soybean Oil) SB - IM MH - Aged MH - Cell Proliferation/drug effects MH - Chemokine CCL2/blood MH - Concanavalin A/immunology/pharmacology MH - Cytokines/*blood MH - Esophageal Neoplasms/surgery MH - *Esophagectomy MH - Esophagus/surgery MH - Fat Emulsions, Intravenous/*administration & dosage/chemistry/pharmacology MH - Female MH - Humans MH - Interleukin-6/blood MH - Male MH - Middle Aged MH - *Parenteral Nutrition MH - Phytohemagglutinins/immunology/pharmacology MH - Soybean Oil/*administration & dosage/chemistry/immunology/pharmacology MH - T-Lymphocytes/*drug effects MH - Tumor Necrosis Factor-alpha/blood EDAT- 2012/03/30 06:00 MHDA- 2013/06/25 06:00 CRDT- 2012/03/30 06:00 PHST- 2012/03/30 06:00 [entrez] PHST- 2012/03/30 06:00 [pubmed] PHST- 2013/06/25 06:00 [medline] AID - 0148607112442216 [pii] AID - 10.1177/0148607112442216 [doi] PST - ppublish SO - JPEN J Parenter Enteral Nutr. 2013 Jan;37(1):123-8. doi: 10.1177/0148607112442216. Epub 2012 Mar 28.